Gefitinib
| Gefitinib | |
|---|---|
| Term | Gefitinib |
| Short definition | GDC-0449 - A drug used to treat advanced basal cell carcinoma that has spread to other parts of the body or has come back after surgery. It is also used in patients who cannot be treated with surgery or radiation therapy. |
| Type | Cancer terms |
| Specialty | Oncology |
| Language | English |
| Source | NCI |
| Comments | |
Gefitinib - (pronounced) (go-FIH-tih-feather) A drug used to treat non-small cell lung cancer that has spread to other parts of the body and has certain mutations (changes) in the EGFR gene. It is used in patients whose cancer has not been treated with other cancer treatments. It is also being studied in the treatment of other types of cancer. Gefitinib blocks certain proteins made by the EGFR gene, which can help stop cancer cells from growing. It can also prevent the growth of new blood vessels that tumors need to grow. Gefitinib is a type of tyrosine kinase inhibitor and a type of anti-angiogenesis drug. Also called Iressa and ZD1839
External links
- Medical encyclopedia article on Gefitinib
- Wikipedia's article - Gefitinib
This WikiMD article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski